1)國井泰人,長岡敦子,日野瑞城,他:精神疾患ブレインバンクと死後脳研究の現在.日本生物学的精神医学会誌 32:179-185, 2021
2)長岡敦子,國井泰人,大沼裕美,他:精神疾患ブレインバンクの現状と課題.精神科 40:416-421, 2022
3)Kunii Y, Ikemoto K, Wada A, et al:Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia:an immunohistochemical study. Med Mol Morphol 44:190-199, 2011
4)Kunii Y, Yabe H, Wada A, et al:Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35:1139-1143, 2011
5)Nishiura K, Kunii Y, Wada A, et al:Profiles of DARPP-32 in the insular cortex with schizophrenia:a postmortem brain study. Prog Neuropsychopharmacol Biol Psychiatry 35:1901-1907, 2011
6)Kleinman JE, Law AJ, Lipska BK, et al:Genetic neuropathology of schizophrenia:new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry 69:140-145, 2011
7)Kunii Y, Hyde TM, Ye T, et al:Revisiting DARPP-32 in postmortem human brain:changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression. Mol Psychiatry 19:192-199, 2014
8)Kunii Y, Zhang W, Xu Q, et al:CHRNA7 and CHRFAM7A mRNAs:co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders. Am J Psychiatry 172:1122-1130, 2015
9)Kunii Y, Miura I, Matsumoto J, et al:Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 53:123-128, 2014
10)Hino M, Kunii Y, Matsumoto J, et al:Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia. J Psychiatr Res 82:100-108, 2016
11)Kunii Y, Hino M, Matsumoto J, et al:Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder. Sci Rep 9:14877, 2019
12)Nagaoka A, Kunii Y, Hino M, et al:ALDH4A1 expression levels are elevated in postmortem brains of patients with schizophrenia and are associated with genetic variants in enzymes related to proline metabolism. J Psychiatr Res 123:119-127, 2020
13)Izumi R, Hino M, Wada A, et al:Detailed Postmortem Profiling of Inflammatory Mediators Expression Revealed Post-inflammatory Alternation in the Superior Temporal Gyrus of Schizophrenia. Front Psychiatry 12:653821, 2021
14)Iwakura Y, Kawahara-Miki R, Kida S, et al:Elevation of EGR1/zif268, a Neural Activity Marker, in the Auditory Cortex of Patients with Schizophrenia and its Animal Model. Neurochem Res 47:2715-2727, 2022
15)Matsumoto J, Nakanishi H, Kunii Y, et al:Decreased 16:0/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia. Sci Rep 7:45050, 2017
16)Kunii Y, Matsumoto J, Izumi R, et al:Evidence for Altered Phosphoinositide Signaling-Associated Molecules in the Postmortem Prefrontal Cortex of Patients with Schizophrenia. Int J Mol Sci 22:8280, 2021
17)Komatsu H, Takeuchi H, Kikuchi Y, et al:Ethnicity-Dependent Effects of Schizophrenia Risk Variants of the OLIG2 Gene on OLIG2 Transcription and White Matter Integrity. Schizophr Bull 46:1619-1628, 2020
18)Insel T, Cuthbert B, Garvey M, et al:Research domain criteria(RDoC):toward a new classification framework for research on mental disorders. Am J Psychiatry 167:748-751, 2010